Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Global Forecast 2023-2030

Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Global Forecast 2023-2030


The Biotechnology & Pharmaceutical Services Outsourcing Market is projected to reach USD 330.17 billion by 2030 from USD 135.51 billion in 2022, at a CAGR of 11.77% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biotechnology & Pharmaceutical Services Outsourcing Market.
  • Based on Services, market is studied across Auditing & Assessment, Consulting, Product Design & Development, Product Maintenance, Product Testing & Validation, Regulatory Affairs, and Training & Education. The Consulting is further studied across Quality Management Systems Consulting, Regulatory Compliance, and Remediation. The Regulatory Affairs is further studied across Clinical Trial Applications & Product Registration, Legal Representation, and Regulatory Writing & Publishing. The Consulting is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Biotech Companies and Pharmaceutical Companies. The Biotech Companies is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biotechnology & Pharmaceutical Services Outsourcing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biotechnology & Pharmaceutical Services Outsourcing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biotechnology & Pharmaceutical Services Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, CEVA Logistics AG, Charles River Laboratories, Inc., Concept Heidelberg GmbH, Curia Global, Inc., Dalton Pharma Services by Seikagaku Corporation, DHL International GmbH, Eurofins Scientific (Ireland) Limited, Evotec SE, GenScript Biotech Corporation, Hitachi Ltd., Icon PLC, IQVIA HOLDINGS, INC., Laboratory Corporation of America Holdings, Lachman Consultant Services, Inc., McKesson Corporation by Aurelius Group, Parexel International Corporation, The Quantic Group, and WuXi AppTec Co., Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Biotechnology & Pharmaceutical Services Outsourcing Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Biotechnology & Pharmaceutical Services Outsourcing Market?
  3. What is the competitive strategic window for identifying opportunities in the Biotechnology & Pharmaceutical Services Outsourcing Market?
  4. What are the latest technology trends and regulatory frameworks in the Biotechnology & Pharmaceutical Services Outsourcing Market?
  5. What is the market share of the leading vendors in the Biotechnology & Pharmaceutical Services Outsourcing Market?
  6. Which modes and strategic moves are suitable for entering the Biotechnology & Pharmaceutical Services Outsourcing Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biotechnology & Pharmaceutical Services Outsourcing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D expenditure of pharmaceutical and biopharmaceutical industry
5.1.1.2. Rising demand for outsourcing services in drug development
5.1.1.3. Growing regulatory support activities including labeling and documentation
5.1.2. Restraints
5.1.2.1. Issues associated with monitoring and lack of standardization
5.1.3. Opportunities
5.1.3.1. Rising outsourcing of generics and biosimilar manufacturing
5.1.3.2. Outsourcing of clinical trial activity
5.1.4. Challenges
5.1.4.1. Issues associated with data security and increasing lead time and logistics costs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Biotechnology & Pharmaceutical Services Outsourcing Market, by Services
6.1. Introduction
6.2. Auditing & Assessment
6.3. Consulting
6.4.1. Quality Management Systems Consulting
6.4.2. Regulatory Compliance
6.4.3. Remediation
6.4. Product Design & Development
6.5. Product Maintenance
6.6. Product Testing & Validation
6.7. Regulatory Affairs
6.8.1. Clinical Trial Applications & Product Registration
6.8.2. Legal Representation
6.8.3. Regulatory Writing & Publishing
6.8. Training & Education
7. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-User
7.1. Introduction
7.2. Biotech Companies
7.3. Pharmaceutical Companies
8. Americas Biotechnology & Pharmaceutical Services Outsourcing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AmerisourceBergen Corporation
12.1.2. CEVA Logistics AG
12.1.3. Charles River Laboratories, Inc.
12.1.4. Concept Heidelberg GmbH
12.1.5. Curia Global, Inc.
12.1.6. Dalton Pharma Services by Seikagaku Corporation
12.1.7. DHL International GmbH
12.1.8. Eurofins Scientific (Ireland) Limited
12.1.9. Evotec SE
12.1.10. GenScript Biotech Corporation
12.1.11. Hitachi Ltd.
12.1.12. Icon PLC
12.1.13. IQVIA HOLDINGS, INC.
12.1.14. Laboratory Corporation of America Holdings
12.1.15. Lachman Consultant Services, Inc.
12.1.16. McKesson Corporation by Aurelius Group
12.1.17. Parexel International Corporation
12.1.18. The Quantic Group
12.1.19. WuXi AppTec Co., Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings